You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic foregut cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)

Not yet recruiting
  • Metastatic Cancer
  • +7 more
  • Standard of Care Chemotherapy
  • +7 more
  • (no location specified)
Apr 1, 2022

Esophageal Cancer, Gastric Cancer Trial in Strasbourg (Near Infra-Red Fluorescence Guided Surgery)

Recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Near Infra-Red Fluorescence Guided Surgery
  • Strasbourg, France
    Service de Chirurgie Digestive et Endocrinienne, NHC
Mar 28, 2022

Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut)

Completed
  • Lung, Prostate, Breast, Colon, Pancreatic, Renal, Bladder,Thyroid, Ovarian, Head and Neck,GI (Foregut - Esophagus),GI (Midgut) Cancer
  • +2 more
  • data collection
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 21, 2021

Metastatic Cancer, Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer Trial (OB-002)

Not yet recruiting
  • Metastatic Cancer
  • +5 more
  • (no location specified)
Jul 10, 2023

Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR

Completed
  • Metastatic Colorectal Adenocarcinoma
    • (no location specified)
    Oct 9, 2023

    Cadonilimab in Recurrent or Metastatic Cervical Cancer

    Not yet recruiting
    • Recurrent or Metastatic Cervical Cancer
    • (no location specified)
    Nov 23, 2023

    HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)

    Not yet recruiting
    • HER2-positive Breast Cancer
    • Trastuzumab deruxtecan
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek
    Aug 7, 2023

    Metastatic Colorectal Cancer Trial in Tanta (Sulfasalazine)

    Recruiting
    • Metastatic Colorectal Cancer
    • Tanta, El-Gharbia Governorate, Egypt
      Tanta University Hospital
    Nov 15, 2023

    Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)

    Recruiting
    • Metastatic Prostate Cancer
    • Nanjing, Jiangsu, China
      Nanjing First Hospital
    Sep 17, 2023

    Metastatic Colorectal Cancer Trial in Tanta (Nitazoxanide)

    Recruiting
    • Metastatic Colorectal Cancer
    • Tanta, El-Gharbia Governorate, Egypt
      Tanta University Hospital
    Sep 17, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Sipuleucel-T Injection
    • (no location specified)
    Nov 10, 2023

    Metastatic Prostate Cancer in Pirkanmaa Hospital District in

    Not yet recruiting
    • Metastatic Castration Sensitive Prostate Cancer (mCSPC)
    • Metastatic Castration Resistant Prostate Cancer (mCRPC)
    • (no location specified)
    Jan 17, 2023

    Refractory Metastatic Colorectal Cancer Trial in Berlin (Radiofrequency electromagnetic field treatment)

    Recruiting
    • Refractory Metastatic Colorectal Cancer
    • Radiofrequency electromagnetic field treatment
    • Berlin, Germany
      Charité Universitätsmedizin Berlin
    Aug 3, 2023

    Metastatic Colorectal Cancer Trial (LB-100, Azenosertib)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • (no location specified)
    Oct 31, 2023

    Metastatic Colorectal Cancer Trial in Nanchang (Fruquintinib)

    Recruiting
    • Metastatic Colorectal Cancer
    • Nanchang, Jiangxi, China
      The First Affiliated Hospital of Nanchang University
    Nov 1, 2023

    Metastatic Breast Cancer Trial (Meritup oral solution)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Meritup oral solution
    • (no location specified)
    Nov 29, 2023

    A Journey Into Participation Patterns Among Metastatic Prostate

    Not yet recruiting
    • Metastatic Prostate Cancer
      • San Francisco, California
        Power Life Sciences
      Aug 18, 2023

      Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

      Not yet recruiting
      • Estrogen-receptor-positive Breast Cancer
      • +3 more
      • elacestrant, palbociclib, abemaciclib, ribociclib
      • Chicago, Illinois
        Northwestern University
      Sep 25, 2023

      Recurrent or Metastatic Colorectal Cancer Trial (Nelmastobart and Capecitabine)

      Not yet recruiting
      • Recurrent or Metastatic Colorectal Cancer
      • Nelmastobart and Capecitabine
      • (no location specified)
      Aug 6, 2023

      Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)

      Recruiting
      • Metastatic Cancer
      • +5 more
      • Written Exposure Therapy
      • Boulder, Colorado
        University of Colorado Boulder
      Sep 13, 2023

      Metastatic Hormone-Sensitive Prostate Cancer Trial (Rezvilutamide, Rezvilutamide plus abiraterone, Continue previous treatment)

      Not yet recruiting
      • Metastatic Hormone-Sensitive Prostate Cancer
      • (no location specified)
      Nov 10, 2023

      Cancer, Colorectal Cancer, Solid Tumor Trial in San Antonio (FOG-001)

      Recruiting
      • Cancer
      • +11 more
      • San Antonio, Texas
        South Texas Accelerated Research Therapeutics, LLC
      Jun 21, 2023

      Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)

      Not yet recruiting
      • Metastatic Colorectal Carcinoma
      • (no location specified)
      Nov 1, 2023

      Metastatic Colorectal Cancer (mCRC) Trial (JMT101, SG001, Irinotecan)

      Not yet recruiting
      • Metastatic Colorectal Cancer (mCRC)
      • (no location specified)
      Oct 13, 2023

      Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

      Recruiting
      • Adenocarcinoma
      • +8 more
      • Radiotherapy targeted to the primary lesion
      • +7 more
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Nov 7, 2023